2.07
price down icon1.90%   -0.04
after-market After Hours: 2.10 0.03 +1.45%
loading
In 8 Bio Inc stock is traded at $2.07, with a volume of 41,998. It is down -1.90% in the last 24 hours and up +3.50% over the past month. IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
See More
Previous Close:
$2.11
Open:
$2.0501
24h Volume:
41,998
Relative Volume:
0.54
Market Cap:
$9.40M
Revenue:
-
Net Income/Loss:
$-31.88M
P/E Ratio:
-2.76
EPS:
-0.75
Net Cash Flow:
$-25.20M
1W Performance:
-1.43%
1M Performance:
+3.50%
6M Performance:
-57.12%
1Y Performance:
-70.01%
1-Day Range:
Value
$2.04
$2.0927
1-Week Range:
Value
$2.04
$2.29
52-Week Range:
Value
$1.91
$16.70

In 8 Bio Inc Stock (INAB) Company Profile

Name
Name
In 8 Bio Inc
Name
Phone
(646) 600-6438
Name
Address
EMPIRE STATE BUILDING, NEW YORK
Name
Employee
18
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
INAB's Discussions on Twitter

Compare INAB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
INAB
In 8 Bio Inc
2.07 9.58M 0 -31.88M -25.20M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-18-24 Initiated Laidlaw Buy
Aug-30-22 Initiated H.C. Wainwright Buy

In 8 Bio Inc Stock (INAB) Latest News

pulisher
07:15 AM

Climb Bio Publishes Long-Term Data on Budoprutug - TradingView

07:15 AM
pulisher
Oct 16, 2025

PALI back in Nasdaq bid-price compliance; 133.0M shares out - Stock Titan

Oct 16, 2025
pulisher
Oct 15, 2025

[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan

Oct 15, 2025
pulisher
Oct 14, 2025

[8-K] Annovis Bio, Inc. Reports Material Event | ANVS SEC FilingForm 8-K - Stock Titan

Oct 14, 2025
pulisher
Oct 14, 2025

[8-K] – Inmune Bio, Inc. (INMB) (CIK 0001711754) - Stock Titan

Oct 14, 2025
pulisher
Oct 14, 2025

Inmune Bio Inc Announces Participation in Dermatologic Panel - TradingView

Oct 14, 2025
pulisher
Oct 14, 2025

Oct 22 CEO Panel: INmune Bio's CORDStrom for RDEB — David Moss at Maxim Growth Summit in NYC - Stock Titan

Oct 14, 2025
pulisher
Oct 13, 2025

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 - GlobeNewswire

Oct 13, 2025
pulisher
Oct 13, 2025

Is Mustang Bio Inc. stock ready for a breakoutJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

OrbiMed Funds Buy into Adicet Bio Offering; Ownership Diluted to 9.6% - Stock Titan

Oct 10, 2025
pulisher
Oct 10, 2025

Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace

Oct 10, 2025
pulisher
Oct 10, 2025

Korro Bio, Inc. (KRRO) Stock Price, News, Quote & History - Yahoo

Oct 10, 2025
pulisher
Oct 09, 2025

Palisade Bio, Inc. Cancels Special Meeting of Stockholders - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

[8-K] PALISADE BIO, INC. Reports Material Event | PALI SEC FilingForm 8-K - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

[SCHEDULE 13G] PALISADE BIO, INC. SEC Filing - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Perceptive Discloses 9.99% Stake in Palisade Bio (12.24M Shares) - Stock Titan

Oct 09, 2025
pulisher
Oct 08, 2025

PALI grants 7,665,800 RSUs to Chief Medical Officer; vesting over 2 years - Stock Titan

Oct 08, 2025
pulisher
Oct 08, 2025

PALI Form 4: 9.18M RSUs granted to director/officer - Stock Titan

Oct 08, 2025
pulisher
Oct 08, 2025

Bio, semiconductor, content firms to reboot Korea’s IPO market - KED Global

Oct 08, 2025
pulisher
Oct 08, 2025

Deep Track discloses 6.43M pre-funded warrants, holds 9.99% of PALI - Stock Titan

Oct 08, 2025
pulisher
Oct 08, 2025

Nuvation Bio Inc. (NUVB): A Bull Case Theory - Insider Monkey

Oct 08, 2025
pulisher
Oct 08, 2025

PlayStation sale round-up for North America October 8, 2025 - TrueTrophies

Oct 08, 2025
pulisher
Oct 08, 2025

Brokerages Set Gossamer Bio, Inc. (NASDAQ:GOSS) Price Target at $8.50 - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

[8-K] Adicet Bio, Inc. Reports Material Event | ACET SEC FilingForm 8-K - Stock Titan

Oct 07, 2025
pulisher
Oct 07, 2025

Morning Market Movers: SPRB, LXEO, BMEA, Seeing Big Swings - RTTNews

Oct 07, 2025
pulisher
Oct 07, 2025

70.0M shares: Adicet Bio Prices $80M Registered Direct Offering - Stock Titan

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet's ADI-001 yields immune-reset signals; Phase 2 targeted Q2 2026 - Stock Titan

Oct 07, 2025
pulisher
Oct 03, 2025

Morning Market Movers: DBVT, CLPT, DWTX, Seeing Big Swings - RTTNews

Oct 03, 2025
pulisher
Oct 02, 2025

$138M Raised: Palisade Bio Closes Upsized Offering to Fund Phase 2 PALI-2108 - Stock Titan

Oct 02, 2025
pulisher
Oct 02, 2025

Biopsy Devices Market Poised for Steady Growth by 2032, Fueled by Innovation and Increasing Surgical Procedures | DelveInsight - The Globe and Mail

Oct 02, 2025
pulisher
Oct 01, 2025

Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NSC - StocksToTrade

Oct 01, 2025
pulisher
Oct 01, 2025

Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical - openPR.com

Oct 01, 2025
pulisher
Oct 01, 2025

Wheeler Bio Appoints Jay Benson as Chief Operating Officer - PR Newswire

Oct 01, 2025
pulisher
Oct 01, 2025

Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock - Yahoo Finance

Oct 01, 2025
pulisher
Sep 30, 2025

Biotech Adicet Bio Issues New Employee Stock Options at $0.81 Under Special Inducement Plan - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Cancer Detection Biotech bioAffinity Technologies Raises $4.8M Through Public Stock Offering at $2.50 - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday - Benzinga

Sep 30, 2025
pulisher
Sep 30, 2025

180-Patient Phase 3 Trial: Nuvation Bio Tests IBTROZI for Early-Stage Lung Cancer Prevention - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Climb Bio stock price target raised to $8 from $7 at BTIG on CLYM116 potential - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

24-Week TSLP Inhibition: Upstream Bio's Verekitug Shows Breakthrough Respiratory Disease Treatment Data - Stock Titan

Sep 30, 2025
pulisher
Sep 29, 2025

KALA BIO Announces Topline Results from CHASE Phase 2b - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint - Yahoo Finance

Sep 29, 2025
pulisher
Sep 29, 2025

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN - GlobeNewswire

Sep 29, 2025
pulisher
Sep 27, 2025

Published on: 2025-09-27 16:04:15 - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

What the charts say about Instil Bio Inc. todayBull Run & Weekly High Potential Stock Alerts - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

What analysts say about INmune Bio Inc stockTechnical Breakout Signals & Free Daily Stock Hotspot Analysis - Early Times

Sep 27, 2025
pulisher
Sep 22, 2025

Can Climb Bio Inc. recover in the next quarter2025 Market Overview & AI Enhanced Execution Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025 - Business Wire

Sep 22, 2025
pulisher
Sep 21, 2025

Cabaletta Bio, Inc. $CABA Shares Purchased by Acadian Asset Management LLC - MarketBeat

Sep 21, 2025
pulisher
Sep 19, 2025

INmune Bio, Inc. (NASDAQ:INMB) Short Interest Down 29.8% in August - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - BioSpace

Sep 19, 2025

In 8 Bio Inc Stock (INAB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Cap:     |  Volume (24h):